TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors
NCT: NCT06373419 · TERMINATED
Brief Summary
The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser enucleation of bladder tumors. The main question it aims to answer is: Is there a difference in pathological and clinical outcomes between MOSES Holmium and Thulium Fiber Laser (TFL) in the transurethral laser enucleation of bladder tumors? Participants will randomized to either TFL of MOSES arm for their bladder resection procedure.
Frequently Asked Questions
What is TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors?
TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors is a clinical trial registered under NCT06373419. Current status: TERMINATED.
What is the status of NCT06373419?
The current status of NCT06373419 (TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors) is: TERMINATED.
When did TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors start?
TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors started on 2023-10-16.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.